Physician profile
Eva Hardy
NPI 1710237516
$1,780.99
in general payments reported to CMS, 2019-2025
10 companies · $1,584 in 2025
The $1,584 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.92 · 2022: $37.12 · 2023: $64.38 · 2024: $59.78 · 2025: $1,584.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,098 · Food and Beverage: $610.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,098.04 |
| Food and Beverage | $609.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,014.90 | 2025 | |
| Tricoast Surgical Solutions LLC | $221.14 | 2025 | |
| Solventum Corporation | $176.77 | 2024-2025 | V.A.C. Veraflo, Prevena |
| Depuy Synthes Sales INC. | $140.02 | 2025 | Va-Lcp |
| Electronic Waveform Lab, INC. | $63.17 | 2021-2023 | |
| Smith+Nephew, INC. | $46.32 | 2023-2025 | Grafix Pl, Stravix, Pico |
| Integra Lifesciences Corporation | $42.86 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Stryker Corporation | $41.01 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $22.32 | 2025 | Xifaxan |
| Baxter Healthcare | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eva Hardy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.